A Ph2b to Evaluate Clinical Efficacy and Safety of Tildacerfont in Adult CAH

NCT04457336 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
96
Enrollment
INDUSTRY
Sponsor class

Stopped Study SPR001-203 did not meet its primary and secondary endpoints therefore Spruce Biosciences has decided to terminate the study

Conditions

Interventions

Sponsor

Spruce Biosciences